Tiziana Life Sciences - ADR Peer Comparison

$1.01

$-0.03 (-2.88%)

As on 25-Sep-2026 16:00EDT

Market cap

$129 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

2569.7

Div. Yield

0 %

Edit

	Tiziana Life Sciences - ADR	Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
Market cap ($ Mln)	129	5,858
Revenue ($ Mln)	--	841
Net Profit ($ Mln)	-18.43	80.66
Net Margin (%)	--	9.59
RoE (%)	-924.32	13.20
Price to Earnings	--	75.84
Price-To-Book	2,569.66	9.07

Cashflow
Ratios

Cashflow ($ Mln)

	Tiziana Life Sciences - ADR	Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
Cash From Operating Activities	-12.85	25.69
Cash Flow from Investing Activities	3.04	37.67
Cash from Financing Activities	10.01	12.27
Net Cash Inflow / Outflow	--	--

Ratios

Profitability Ratios

	Tiziana Life Sciences - ADR	Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
ROCE (%)	-810.15	11.51
ROE (%)	-924.32	11.73
ROA (%)	-161.82	8.78
EBIT Margin (%)	--	--
Net Margin (%)	--	8.71
Cash Profit Margin (%)	--	--

Growth Ratios

	Tiziana Life Sciences - ADR	Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
Revenue Growth (%)	--	0.60
EBIT Growth (%)	--	--
Net Profit Growth (%)	-55.37	236.61
EPS Growth (%)	-0.37	2.25
Book Value Growth (%)	--	--

Valuation Ratios

	Tiziana Life Sciences - ADR	Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
Price / Earnings	-4.72	55.21
Price / Book Value	1,673.77	5.74
Dividend Yield (%)	--	--
EV/EBITDA	-4.59	31.56
Market Cap ($ Cr)	--	--

Solvency Ratios

	Tiziana Life Sciences - ADR	Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
Debt to Equity	8.77	0.02
Short term debt to equity ratio	4.27	0.01
Current Ratio	0.76	3.79
Quick Ratio	--	3.39
Interest Coverage	-1,022.94	--

Operating Efficiency Ratios

	Tiziana Life Sciences - ADR	Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
Debtors to sales (%)	--	2.30
Asset Turnover	0.00	1.01
Receivable days	--	15.45
Inventory Days	--	48.27
Payable days	9,953.06	2.42
Cash Conversion Cycle	--	61.31

Annual
Quarterly